Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice
2008

Anti-Human Tissue Factor Antibody Helps Lung Injury in Mice

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): He Xiaolin, Han Bing, Mura Marco, Li Li, Cypel Marcelo, Soderman Avery, Picha Kristen, Yang Jing, Liu Mingyao

Primary Institution: University Health Network Toronto General Research Institute, University of Toronto

Hypothesis

Can a humanized anti-tissue factor monoclonal antibody reduce acute lung injury in a mouse model?

Conclusion

The anti-hTF antibody significantly reduced lung injury caused by intestinal ischemia-reperfusion in mice.

Supporting Evidence

  • The anti-hTF mAb reduced lung injury scores significantly.
  • Treatment with CNTO859 decreased total cell counts in bronchoalveolar lavage fluid.
  • The antibody reduced alveolar fibrin deposition and inflammatory responses.

Takeaway

Researchers found that a special antibody can help protect mice's lungs from damage after a surgery that cuts off blood flow to the intestines.

Methodology

The study used human tissue factor knock-in mice and administered a humanized anti-tissue factor monoclonal antibody to assess its effects on lung injury.

Limitations

The study was limited by the availability of a humanized IgG for comparison.

Participant Demographics

Male hTF-KI mice aged 6-8 weeks, weighing 25-30 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001527

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication